$4.33
+
$0.34 (7.85%)
End-of-day quote: 04/30/2024
NasdaqGS:NVAX
Novavax Competitors
| Ticker | Name | Exchange | Consensus | Price | Price Target | Upside/Downside | Analysts | Market Cap |
|---|---|---|---|---|---|---|---|---|
| JNJ | Johnson & Johnson | NYSE | Outperform | $151.18 | $174.55 | 0.00% | 3 | $348.43B |
| MRK | Merck | NYSE | Outperform | $128.80 | $130.51 | 0.00% | 11 | $327.32B |
| AZN | AstraZeneca PLC | LSE | Outperform | £121.70 | £165.99 | 0.00% | 16 | £186.99B |
| PFE | Pfizer | NYSE | Outperform | $27.18 | $32.87 | 0.00% | 6 | $153.91B |
| GSK | GSK | LSE | Outperform | £17.05 | £17.30 | 0.00% | 12 | £69.53B |
| MRNA | Moderna | NasdaqGS | Outperform | $111.46 | $135.42 | 0.00% | 1 | $42.24B |
| 4502 | Takeda Pharmaceutical Company | TSE | Outperform | ¥4.14k | ¥4.74k | 0.00% | 0 | ¥6.52T |
| BNTX | BioNTech | NasdaqGS | Outperform | $89.95 | $123.75 | 0.00% | 3 | $21.40B |
| DVAX | Dynavax Technologies | NasdaqGS | Outperform | $11.68 | $25.00 | 0.00% | 1 | $1.49B |
| VBIV | VBI Vaccines | NasdaqCM | Outperform | $0.57 | $6.00 | 0.00% | 0 | $18.02M |
